Advertisement

Iowa declares the demise of CoOportunity Health

By Bob Herman  |  January 23, 2015

The Iowa Insurance Division said Friday that not-for-profit health insurer CoOportunity Health could not be saved and ordered its liquidation by the end of February.

Financing questions loom as private LTC insurers falter

Financing questions loom as private LTC insurers falter

By Steven Ross Johnson  |  January 17, 2015

A growing number of Americans are expected to need long-term-care services such as nursing home and home health care in the coming years. But experts increasingly doubt that private LTC insurance alone is a viable way to finance that care.

Whistling past the graveyard on Obamacare threats

By Harris Meyer  |  January 17, 2015

Top healthcare executives who gathered in San Francisco this past week at the J.P. Morgan Healthcare Conference widely agreed that the healthcare reform law's coverage expansion and other provisions are not in jeopardy at the hands of congressional Republicans or the Supreme Court. Really?

Aetna inks discount deal for Gilead's hepatitis C drugs

Aetna inks discount deal for Gilead's hepatitis C drugs

By Bob Herman  |  January 16, 2015

Aetna has agreed to a deal with Gilead Sciences to give preference to the drugmaker's hepatitis C drugs. It's the fourth straight agreement where a payer or benefits manager has chosen Gilead over competitor AbbVie.

Aetna competitors unlikely to match $16 minimum wage move

Aetna competitors unlikely to match $16 minimum wage move

By Bob Herman  |  January 14, 2015

Aetna competitors have no plans to follow its lead by raising employees' minimum wage to $16 an hour while also improving their health benefits, according to those interviewed at the J.P. Morgan Healthcare Conference in San Francisco.

J.P. Morgan Healthcare Conference: Day 2 notebook

J.P. Morgan Healthcare Conference: Day 2 notebook

By Bob Herman  |  January 14, 2015

Insurers were bullish on their prospects and circumspect on an expected rash of M&A. Aetna CEO Mark Bertolini said it will “take one big transaction to tip the whole thing off.”

Humana opts for Gilead in hepatitis C drug battle

By Bob Herman  |  January 14, 2015

Humana acknowledged late Tuesday it has an exclusive deal to offer Gilead Sciences' hepatitis C drugs to its members. The company's announcement is the latest in a string of bargaining battles between health insurers and pharmacy benefits managers and pharmaceutical companies.

Insurers eyeing expansion through M&A in 2015

By Bob Herman  |  January 10, 2015

Health insurance merger and acquisition activity, quiet for the past two years, may pick up in 2015 as insurers become comfortable with reform's operating rules and hunger for expansion in the lucrative Medicare and Medicaid markets, industry observers say.

Insurers will be dipping their toes in takeover waters in 2015

By Bob Herman  |  January 08, 2015

The health insurance merger and acquisition scene has been noticeably quiet for the past two years. But consensus is building among industry observers that activity should pick up in 2015 as insurers become more comfortable with healthcare reform’s new operating environment.

Advertisement
Modern Healthcare Daily

The top stories in healthcare business every day

The Modern Healthcare Daily News App provides you with registration-free access to the top trending healthcare business news. It's the only news you need each day.